Skip to main content
TipRanks
Go Ultimate75% OFF
Orbital Therapeutics logo

Orbital Therapeutics: Valuation, Funding & Investors

100 Binney St Cambridge, Massachusetts 02142, UShttps://www.orbitaltx.com/Therapeutics

Orbital Therapeutics is an early-stage biotechnology company focused on developing RNA-based medicines. Founded in 2022, the company is advancing its lead program, OTX-201, a potential in vivo CAR T treatment for autoimmune conditions that uses lipid nanoparticles to deliver RNA into patient cells. This innovative approach aims to enable the body to produce targeted T cells to combat disease, with the treatment currently in preclinical stages.

Leadership & Board

Key Executives

Chief Financial Officer
Terry-Ann Burrell
Co-Founder and Chairman
Peter Barrett
Chief Operating Officer
Gillian Ivers-Read
President and Chief Scientific Officer
Giuseppe Ciaramella
Co-Founder
Nathaniel Brooks Horwitz
Current Number of Employees
9
Current LinkedIn Followers
18,397

Latest Estimated Valuation

Total Amount Raised
$270M
Total Funding Rounds
1
Latest Funding Amount
$270M
Latest Funding Round
Series A

Employee Trend

Orbital Therapeutics had 9 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

9Latest Employee Count
0(0.00%)Week-Over-Week Change
020406080Dec 29, 2025Jan 12, 2026Jan 26, 2026Feb 10, 2026Feb 23, 2026Mar 09, 2026Mar 23, 2026Apr 06, 2026Apr 27, 2026May 11, 2026May 25, 2026Jun 08, 2026Jun 22, 2026Jul 06, 2026Jul 27, 2026Aug 10, 2026Aug 24, 2026Sep 07, 2026Sep 21, 2026Oct 05, 2026Oct 19, 2026Nov 02, 2026Nov 16, 2026

Social Trend

Orbital Therapeutics had 18,397 followers as of November 16, 2026. The number of followers increased by 5 (0.03%) week-over-week.

18,397Latest Followers Count
5(0.03%)Week-Over-Week Change
05,00010,00015,00020,000Dec 29, 2025Jan 12, 2026Jan 26, 2026Feb 10, 2026Feb 23, 2026Mar 09, 2026Mar 23, 2026Apr 06, 2026Apr 27, 2026May 11, 2026May 25, 2026Jun 08, 2026Jun 22, 2026Jul 06, 2026Jul 27, 2026Aug 10, 2026Aug 24, 2026Sep 07, 2026Sep 21, 2026Oct 05, 2026Oct 19, 2026Nov 02, 2026Nov 16, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Oct 10, 2025Series A$270.00M―

Similar Companies

A snapshot of private companies similar to Orbital Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis